Modelling primaquine-induced haemolysis in G6PD deficiency
© Watson et al. Primaquine is the only drug available to prevent relapse in vivax malaria. The main adverse effect of primaquine is erythrocyte age and dose-dependent acute haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). As testing for G6PDd is often unav...
Saved in:
Main Authors: | James Watson, Walter R.J. Taylor, Didier Menard, Sim Kheng, Nicholas J. White |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/42021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2019) -
The course of primaquine induced haemolysis in G 6 PD deficient Thais
by: P. Charoenlarp, et al.
Published: (2018) -
Single low dose primaquine (0.25mg/kg) does not cause clinically significant haemolysis in G6PD deficient subjects
by: Germana Bancone, et al.
Published: (2018) -
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria
by: Kesara Na Bangchang, et al.
Published: (2018) -
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
by: Nicholas J. White, et al.
Published: (2018)